341 related articles for article (PubMed ID: 33121646)
1. Use of Antenatal Corticosteroids in Preterm Prelabor Rupture of Membranes.
Battarbee AN
Obstet Gynecol Clin North Am; 2020 Dec; 47(4):587-594. PubMed ID: 33121646
[TBL] [Abstract][Full Text] [Related]
2. Booster course of antenatal corticosteroids after preterm prelabor rupture of membranes: a double-blind randomized trial.
Porreco R; Garite TJ; Combs CA; Maurel K; Huls CK; Baker S; Fortner KB; Longo SA; Nageotte M; Lewis D; Tran L;
Am J Obstet Gynecol MFM; 2023 May; 5(5):100896. PubMed ID: 36796641
[TBL] [Abstract][Full Text] [Related]
3. Antenatal corticosteroids for pregnant women with COVID-19 infection and preterm prelabor rupture of membranes: a decision analysis.
Zhou CG; Packer CH; Hersh AR; Caughey AB
J Matern Fetal Neonatal Med; 2022 May; 35(9):1643-1651. PubMed ID: 32429722
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of preterm birth complications by antenatal corticosteroid administration].
Schmitz T
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1399-1417. PubMed ID: 27776846
[TBL] [Abstract][Full Text] [Related]
5. Effect of obesity on neonatal outcomes in pregnancies with preterm premature rupture of membranes.
Faucett AM; Metz TD; DeWitt PE; Gibbs RS
Am J Obstet Gynecol; 2016 Feb; 214(2):287.e1-287.e5. PubMed ID: 26435047
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes.
Vermillion ST; Soper DE; Bland ML; Newman RB
Am J Obstet Gynecol; 2000 Oct; 183(4):925-9. PubMed ID: 11035339
[TBL] [Abstract][Full Text] [Related]
7. Controversies in antenatal corticosteroids.
Shanks AL; Grasch JL; Quinney SK; Haas DM
Semin Fetal Neonatal Med; 2019 Jun; 24(3):182-188. PubMed ID: 31155465
[TBL] [Abstract][Full Text] [Related]
8. A comparison of 2 doses of antenatal dexamethasone for the prevention of respiratory distress syndrome: an open-label, noninferiority, pragmatic randomized trial.
Chawanpaiboon S; Chukaew R; Pooliam J
Am J Obstet Gynecol; 2024 Feb; 230(2):260.e1-260.e19. PubMed ID: 37442247
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of antenatal steroids in obstetric subgroups.
Elimian A; Verma U; Canterino J; Shah J; Visintainer P; Tejani N
Obstet Gynecol; 1999 Feb; 93(2):174-9. PubMed ID: 9932550
[TBL] [Abstract][Full Text] [Related]
10. Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes.
Battarbee AN; Ros ST; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Andrews W; Saade G; Sadovsky Y; Reddy UM; Varner MW; Manuck TA;
Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100077. PubMed ID: 32905377
[TBL] [Abstract][Full Text] [Related]
11. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.
Crowther CA; Haslam RR; Hiller JE; Doyle LW; Robinson JS;
Lancet; 2006 Jun; 367(9526):1913-9. PubMed ID: 16765760
[TBL] [Abstract][Full Text] [Related]
12. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
Lorthe E; Torchin H; Delorme P; Ancel PY; Marchand-Martin L; Foix-L'Hélias L; Benhammou V; Gire C; d'Ercole C; Winer N; Sentilhes L; Subtil D; Goffinet F; Kayem G
Am J Obstet Gynecol; 2018 Sep; 219(3):298.e1-298.e14. PubMed ID: 29852153
[TBL] [Abstract][Full Text] [Related]
13. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial.
Guinn DA; Atkinson MW; Sullivan L; Lee M; MacGregor S; Parilla BV; Davies J; Hanlon-Lundberg K; Simpson L; Stone J; Wing D; Ogasawara K; Muraskas J
JAMA; 2001 Oct; 286(13):1581-7. PubMed ID: 11585480
[TBL] [Abstract][Full Text] [Related]
14. Antenatal corticosteroid therapy in premature infants.
Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M
Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
[TBL] [Abstract][Full Text] [Related]
15. Do antenatal corticosteroids help in the setting of preterm rupture of membranes?
Harding JE; Pang J; Knight DB; Liggins GC
Am J Obstet Gynecol; 2001 Jan; 184(2):131-9. PubMed ID: 11174492
[TBL] [Abstract][Full Text] [Related]
16. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
Roberts D; Dalziel S
Cochrane Database Syst Rev; 2006 Jul; (3):CD004454. PubMed ID: 16856047
[TBL] [Abstract][Full Text] [Related]
17. Antenatal corticosteroid treatment: factors other than lung maturation.
Haram K; Mortensen JH; Magann EF; Morrison JC
J Matern Fetal Neonatal Med; 2017 Jun; 30(12):1437-1441. PubMed ID: 27487405
[TBL] [Abstract][Full Text] [Related]
18. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
Bond DM; Middleton P; Levett KM; van der Ham DP; Crowther CA; Buchanan SL; Morris J
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004735. PubMed ID: 28257562
[TBL] [Abstract][Full Text] [Related]
19. Antenatal corticosteroids beyond 34 weeks gestation: What do we do now?
Kamath-Rayne BD; Rozance PJ; Goldenberg RL; Jobe AH
Am J Obstet Gynecol; 2016 Oct; 215(4):423-30. PubMed ID: 27342043
[TBL] [Abstract][Full Text] [Related]
20. Antenatal corticosteroids for women at risk of preterm delivery: the "Emperor's New Clothes" tale in medical practice.
Beksac MS; Korkmaz A; Kasapoglu T; Ozdemir P; Cosgun E; Tanacan A
J Matern Fetal Neonatal Med; 2022 Feb; 35(4):705-712. PubMed ID: 32093542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
